Barclays’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $736M | Sell |
5,282,196
-3,833,287
| -42% | -$537M | 0.18% | 85 |
|
|
2025
Q4 | $1.12B | Buy |
9,115,483
+3,942,335
| +76% | +$479M | 0.27% | 49 |
|
|
2025
Q3 | $574M | Sell |
5,173,148
-923,527
| -15% | -$105M | 0.12% | 107 |
|
|
2025
Q2 | $676M | Buy |
6,096,675
+492,410
| +9% | +$52.4M | 0.15% | 82 |
|
|
2025
Q1 | $628M | Buy |
5,604,265
+1,204,178
| +27% | +$124M | 0.18% | 81 |
|
|
2024
Q4 | $406M | Buy |
4,400,087
+171,289
| +4% | +$15.4M | 0.11% | 115 |
|
|
2024
Q3 | $355M | Sell |
4,228,798
-427,594
| -9% | -$32.6M | 0.09% | 151 |
|
|
2024
Q2 | $319M | Sell |
4,656,392
-2,151,007
| -32% | -$144M | 0.1% | 157 |
|
|
2024
Q1 | $499M | Buy |
6,807,399
+1,127,429
| +20% | +$86.7M | 0.17% | 103 |
|
|
2023
Q4 | $460M | Buy |
5,679,970
+1,859,883
| +49% | +$145M | 0.17% | 99 |
|
|
2023
Q3 | $286M | Sell |
3,820,087
-2,822,823
| -42% | -$217M | 0.18% | 118 |
|
|
2023
Q2 | $512M | Buy |
6,642,910
+2,126,182
| +47% | +$170M | 0.32% | 59 |
|
|
2023
Q1 | $375M | Sell |
4,516,728
-1,470,740
| -25% | -$122M | 0.17% | 68 |
|
|
2022
Q4 | $514M | Buy |
5,987,468
+4,138,589
| +224% | +$328M | 0.23% | 59 |
|
|
2022
Q3 | $114M | Sell |
1,848,879
-293,188
| -14% | -$18.5M | 0.12% | 160 |
|
|
2022
Q2 | $132M | Sell |
2,142,067
-778,053
| -27% | -$48.2M | 0.08% | 183 |
|
|
2022
Q1 | $174M | Sell |
2,920,120
-2,440,498
| -46% | -$156M | 0.14% | 154 |
|
|
2021
Q4 | $389M | Buy |
5,360,618
+2,272,720
| +74% | +$157M | 0.15% | 118 |
|
|
2021
Q3 | $216M | Buy |
3,087,898
+396,577
| +15% | +$27.9M | 0.1% | 169 |
|
|
2021
Q2 | $185M | Buy |
2,691,321
+44,088
| +2% | +$2.94M | 0.09% | 184 |
|
|
2021
Q1 | $171M | Buy |
2,647,233
+792,952
| +43% | +$51.1M | 0.09% | 177 |
|
|
2020
Q4 | $108M | Buy |
1,854,281
+416,094
| +29% | +$25.1M | 0.06% | 253 |
|
|
2020
Q3 | $90.9M | Buy |
1,438,187
+305,188
| +27% | +$21.2M | 0.05% | 256 |
|
|
2020
Q2 | $87.2M | Sell |
1,132,999
-1,283,828
| -53% | -$98.4M | 0.07% | 217 |
|
|
2020
Q1 | $181M | Sell |
2,416,827
-497,581
| -17% | -$34.4M | 0.14% | 97 |
|
|
2019
Q4 | $189M | Sell |
2,914,408
-930,759
| -24% | -$60.6M | 0.11% | 153 |
|
|
2019
Q3 | $244M | Buy |
3,845,167
+1,062,999
| +38% | +$69.5M | 0.15% | 104 |
|
|
2019
Q2 | $188M | Buy |
2,782,168
+165,238
| +6% | +$10.9M | 0.12% | 141 |
|
|
2019
Q1 | $170M | Buy |
2,616,930
+21,421
| +0.8% | +$1.42M | 0.12% | 136 |
|
|
2018
Q4 | $162M | Buy |
2,595,509
+414,108
| +19% | +$28.9M | 0.13% | 114 |
|
|
2018
Q3 | $168M | Sell |
2,181,401
-95,433
| -4% | -$7.21M | 0.12% | 127 |
|
|
2018
Q2 | $161M | Sell |
2,276,834
-668,208
| -23% | -$47.2M | 0.14% | 116 |
|
|
2018
Q1 | $222M | Buy |
2,945,042
+208,297
| +8% | +$16.6M | 0.17% | 98 |
|
|
2017
Q4 | $196M | Buy |
2,736,745
+713,552
| +35% | +$54.2M | 0.16% | 112 |
|
|
2017
Q3 | $164M | Sell |
2,023,193
-3,216,284
| -61% | -$246M | 0.17% | 95 |
|
|
2017
Q2 | $371M | Buy |
5,239,477
+775,798
| +17% | +$51.6M | 0.4% | 30 |
|
|
2017
Q1 | $303M | Buy |
4,463,679
+9,007
| +0.2% | +$633K | 0.33% | 38 |
|
|
2016
Q4 | $319M | Buy |
4,454,672
+986,353
| +28% | +$73.3M | 0.34% | 31 |
|
|
2016
Q3 | $274M | Buy |
3,468,319
+2,014,666
| +139% | +$164M | 0.3% | 41 |
|
|
2016
Q2 | $121M | Sell |
1,453,653
-2,778,798
| -66% | -$247M | 0.16% | 102 |
|
|
2016
Q1 | $385M | Buy |
4,232,451
+2,654,236
| +168% | +$239M | 0.59% | 18 |
|
|
2015
Q4 | $159M | Sell |
1,578,215
-633,576
| -29% | -$65.9M | 0.19% | 87 |
|
|
2015
Q3 | $217M | Sell |
2,211,791
-40,600
| -2% | -$4.51M | 0.26% | 52 |
|
|
2015
Q2 | $264M | Sell |
2,252,391
-573,080
| -20% | -$62.6M | 0.3% | 35 |
|
|
2015
Q1 | $277M | Sell |
2,825,471
-490,512
| -15% | -$49.8M | 0.32% | 36 |
|
|
2014
Q4 | $312M | Sell |
3,315,983
-251,624
| -7% | -$26M | 0.3% | 44 |
|
|
2014
Q3 | $378M | Buy |
3,567,607
+1,867,671
| +110% | +$183M | 0.36% | 32 |
|
|
2014
Q2 | $139M | Sell |
1,699,936
-3,024,086
| -64% | -$235M | 0.15% | 92 |
|
|
2014
Q1 | $331M | Buy |
4,724,022
+3,082,462
| +188% | +$242M | 0.37% | 37 |
|
|
2013
Q4 | $123M | Buy |
1,641,560
+244,354
| +17% | +$17M | 0.13% | 120 |
|
|
2013
Q3 | $86.6M | Buy |
1,397,206
+253,079
| +22% | +$15.1M | 0.1% | 154 |
|
|
2013
Q2 | $58.7M | Buy |
+1,144,127
| New | +$59.6M | 0.07% | 220 |
|
Other funds holding GILD
VCM
VPM
Barclays's GILD Position: Q1 2026 in Review
Barclays reduced its Gilead Sciences (GILD) stake by 42% in Q1 2026, selling an estimated $537M and leaving 5,282,196 shares worth $736M. The position accounts for 0.18% of the portfolio, ranked #85.
Barclays first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.12B in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Barclays held 5,282,196 shares of Gilead Sciences worth $736M as of Q1 2026.
- Barclays sold 3,833,287 Gilead Sciences shares in Q1 2026, an estimated $537M.
- Gilead Sciences made up 0.18% of Barclays's portfolio in Q1 2026, its #85 holding.
- Barclays first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Barclays's Gilead Sciences position peaked at $1.12B in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.